<DOC>
	<DOCNO>NCT01627080</DOCNO>
	<brief_summary>The goal clinical research study learn radiation receive esophageal cancer may cause heart create protein call cardiac biomarkers . When cardiac biomarkers normal level , may heart damage . The relationship cardiac biomarkers radiation therapy well study . Learning relationship may lead good way check heart radiation therapy predict heart problem .</brief_summary>
	<brief_title>Cardiac Biomarker Study Esophageal Cancer Patients Treated With Chemotherapy Radiation</brief_title>
	<detailed_description>If find eligible agree take part study , baseline test . The following test procedure perform within 1-2 week start radiation : - You ask health problem may . - Your performance status record . - Blood ( 2 teaspoon ) draw routine test . - Blood ( 1 teaspoon ) drawn measure cardiac biomarkers . - You electrocardiogram ( ECG ) check heart function . - If study doctor think need , exam cardiologist ( doctor diagnose treat heart problem ) check result ECG . Study Visits : Blood ( 1 teaspoon ) drawn measure cardiac biomarkers follow time point : - Within 12-24 hour start radiation - One ( 1 ) time third week radiation - Within 48 hour completion radiation Follow-Up : About 1 2 month complete radiation therapy , depend doctor decide , return clinic . The following test procedure perform : - Blood ( 1 teaspoon ) drawn measure cardiac biomarkers . - You ECG . Length Study Participation : You study follow-up visit . You longer able take part study disease get bad , intolerable side effect occur , unable follow study direction . This investigational study . Using cardiac biomarkers check heart radiation therapy predict future heart problem consider investigational . Up 100 patient enrol study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>1 . Patients histologically proven esophageal cancer treat RT concurrent chemotherapy final dose &gt; /=40 Gy include study . 2 . Patients mid thoracic , distal esophageal , gastroesophageal junction tumor . 3 . All patient must sign studyspecific inform consent form . If patient 's mental status preclude his/her give inform consent , write informed consent may give patient 's legal representative . 4 . Age &gt; /= 18 5 . Women childbearing potential ( A woman childbearing potential sexually mature woman undergone hysterectomy naturally postmenopausal least 24 consecutive month [ i.e. , menses time precede 24 consecutive month ] . For woman childbearing potential , blood pregnancy test must perform within 72 hour prior start protocol treatment . 6 . Induction chemotherapy allow . 7 . Being able meet radiation dose constraint atrisk organ . 1 . Patients receive cardiotoxic drug , trastuzumab adriamycin part chemotherapy regimen . 2 . Patients recent myocardial infarction past month , decompensated heart failure myocarditis/pericarditis past month . 3 . Patients renal failure indicate glomerular filtration rate ( GFR ) &lt; 30 mL/min/1.73sq.m . 4 . Patients intensive care unit ( ICU ) . 5 . Patients systemic sepsis . 6 . Patients acute pulmonary embolism past month . 7 . Women pregnant nursing eligible treatment involve unforeseeable risk fetus child . 8 . Inability obtain histologic proof malignancy . 9 . Patients proximal / cervical esophageal cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Esophagus</keyword>
	<keyword>Esophageal Cancer</keyword>
	<keyword>Radiation therapy</keyword>
	<keyword>RT</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Mid thoracic tumor</keyword>
	<keyword>Distal esophageal tumor</keyword>
	<keyword>Gastroesophageal junction tumor</keyword>
	<keyword>Cardiac biomarkers</keyword>
</DOC>